Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

…, AM Fillet, J Gozlan, R Lancar, N Boukli… - Aids, 2000 - journals.lww.com
Objective: To evaluate the efficacy and safety of the foscarnet–ganciclovir combination in
induction therapy (IT) and maintenance therapy (MT) for cytomegalovirus (CMV) central …

One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance

N Boukli, C Flamand, KL Chea, L Heng, S Keo… - Frontiers in …, 2023 - frontiersin.org
Molecular multiplex assays (MPAs) for simultaneous detection of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), influenza and respiratory syncytial virus (RSV) in a …

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads

N Boukli, A Boyd, M Collot, JL Meynard… - Journal of …, 2018 - academic.oup.com
Objectives To investigate the extent to which drug resistance can be evaluated from proviral
HIV-1 DNA genotype compared with RNA genotype at different timepoints. Patients and …

Is Madagascar at the edge of a generalised HIV epidemic? Situational analysis

…, HZ Andriamahenina, C Dezé, N Boukli… - Sexually Transmitted …, 2021 - sti.bmj.com
Objectives To describe the epidemiological situation of the HIV/AIDS epidemic and to
identify the main drivers for vulnerability in Madagascar. Design Literature review, qualitative …

Targeted HIV screening in eight emergency departments: the DICI-VIH cluster-randomized Two-Period crossover trial

…, S Maylin, B Bercot, P Campa, N Valin, N Boukli… - Annals of emergency …, 2018 - Elsevier
Study objective This study compares the effectiveness and cost-effectiveness of nurse-driven
targeted HIV screening alongside physician-directed diagnostic testing (intervention …

High incidence of false-positive results in patients with acute infections other than COVID-19 by the Liaison SARS-CoV-2 commercial chemiluminescent microparticle …

N Boukli, M Le Mene, A Schnuriger… - Journal of clinical …, 2020 - Am Soc Microbiol
Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), is a major pandemic (1). Diagnosis is based on detection of viral RNA, …

Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021

…, WF Ying, J Jayakumar, VS Horm, N Boukli… - Virus …, 2023 - academic.oup.com
The first case of coronavirus disease 2019 (COVID-19) in Cambodia was confirmed on 27
January 2020 in a traveller from Wuhan. Cambodia subsequently implemented strict travel …

Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

…, A Carol, G Carcelain, J Villemonteix, N Boukli… - European Journal of …, 2021 - Springer
We report evaluation of 30 assays’ (17 rapid tests (RDTs) and 13 automated/manual ELISA/CLIA
assay (IAs)) clinical performances with 2594 sera collected from symptomatic patients …

Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value

…, V Marinho, Y Michel, K Saloum, N Boukli… - … and Infectious Disease, 2021 - Elsevier
RT-PCR is the reference method for diagnosis of a Severe Acute Respiratory Syndrome-Coronavirus-2
(SARS-CoV-2) infection. During the setting up of 6 SARS-CoV-2 RT-PCR assays …

Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection

N Boukli, A Boyd, N Wendremaire, PM Girard… - Sexually transmitted …, 2018 - sti.bmj.com
Narjis Boukli1, … Correspondence to Dr Narjis Boukli, AP-HP, Centre Hospitalo-Universitaire
Saint-Antoine… to the corresponding author of the study (Narjis Boukli at narjis.boukli@aphp.fr). …